Mixtures | Cell viability (%) | ||
---|---|---|---|
Oral epithelial cells | Gingival fibroblasts | SCAP | |
None (control) | 100 | 100 | 111.8 ± 9.5 |
Nisin (25 µg/mL)/Glabridin (50 µg/mL) | 71.5 ± 9.2* | 82.5 ± 5* | 5.0 ± 2.1* |
Nisin (12.5 µg/mL)/Glabridin (25 µg/mL) | 115.0 ± 19.4 | 148.2 ± 11.0 | 122.4 ± 3.6 |
Nisin (25 µg/mL)/Licoricidin (12.5 µg/mL) | 134.3 ± 2.4 | 116.0 ± 2.5 | 107.2 ± 6.0 |
Nisin (12.5 µg/mL)/Licoricidin (6.25 µg/mL) | 131.1 ± 3.6 | 113.5 ± 5.4 | 104.2 ± 8.4 |
Nisin (25 µg/mL)/Licochalcone A (25 µg/mL) | 139.3 ± 4.2 | 99.8 ± 14.1 | 116.9 ± 6.7 |
Nisin (12.5 µg/mL)/Licochalcone A (12.5 µg/mL) | 137.0 ± 5.6 | 104.0 ± 18.3 | 114.4 ± 4.5 |